See more : IVE Group Limited (IGL.AX) Income Statement Analysis – Financial Results
Complete financial analysis of ResMed Inc. (RMD) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of ResMed Inc., a leading company in the Medical – Instruments & Supplies industry within the Healthcare sector.
- Hafnia Limited (HAFNIO.OL) Income Statement Analysis – Financial Results
- PTT Public Company Limited (PTT-R.BK) Income Statement Analysis – Financial Results
- Ribbit LEAP, Ltd. (LEAP-UN) Income Statement Analysis – Financial Results
- Ozner Water International Holding Limited (2014.HK) Income Statement Analysis – Financial Results
- Atea ASA (ATEAY) Income Statement Analysis – Financial Results
ResMed Inc. (RMD)
About ResMed Inc.
ResMed Inc. develops, manufactures, distributes, and markets medical devices and cloud-based software applications for the healthcare markets. The company operates in two segments, Sleep and Respiratory Care, and Software as a Service. It offers various products and solutions for a range of respiratory disorders, including technologies to be applied in medical and consumer products, ventilation devices, diagnostic products, mask systems for use in the hospital and home, headgear and other accessories, dental devices, and cloud-based software informatics solutions to manage patient outcomes, as well as provides customer and business processes. The company also provides AirView, a cloud-based system that enables remote monitoring and changing of patients' device settings; myAir, a personalized therapy management application for patients with sleep apnea that provides support, education, and troubleshooting tools for increased patient engagement and improved compliance; U-Sleep, a compliance monitoring solution that enables home medical equipment (HME)to streamline their sleep programs; connectivity module and propeller solutions; and Propeller portal. It offers out-of-hospital software solution, such as Brightree business management software and service solutions to providers of HME, pharmacy, home infusion, orthotics, and prosthetics services; MatrixCare care management and related ancillary solutions to senior living, skilled nursing, life plan communities, home health, home care, and hospice organizations, as well as related accountable care organizations; and HEALTHCAREfirst that offers electronic health record, software, billing and coding services, and analytics for home health and hospice agencies. The company markets its products primarily to sleep clinics, home healthcare dealers, and hospitals through a network of distributors and direct sales force in approximately 140 countries. ResMed Inc. was founded in 1989 and is headquartered in San Diego, California.
| Metric | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1999 | 1998 | 1997 | 1996 | 1995 | 1994 | 1993 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 4.69B | 4.22B | 3.58B | 3.20B | 2.96B | 2.61B | 2.34B | 2.07B | 1.84B | 1.68B | 1.55B | 1.51B | 1.37B | 1.24B | 1.09B | 920.74M | 835.40M | 716.33M | 607.00M | 425.51M | 339.34M | 273.57M | 204.08M | 155.16M | 115.62M | 88.60M | 66.50M | 49.20M | 34.60M | 23.50M | 13.90M | 7.70M |
| Cost of Revenue | 2.03B | 1.87B | 1.55B | 1.36B | 1.24B | 1.07B | 978.03M | 864.99M | 772.22M | 667.52M | 565.19M | 573.80M | 547.78M | 501.82M | 436.87M | 366.93M | 341.65M | 331.84M | 230.10M | 150.65M | 122.60M | 100.48M | 70.83M | 50.38M | 30.74M | 24.80M | 19.40M | 17.70M | 15.70M | 10.70M | 5.90M | 2.90M |
| Gross Profit | 2.66B | 2.36B | 2.02B | 1.84B | 1.72B | 1.54B | 1.36B | 1.20B | 1.07B | 1.01B | 989.79M | 940.66M | 820.74M | 741.33M | 655.48M | 553.80M | 493.75M | 384.49M | 376.90M | 274.86M | 216.74M | 173.09M | 133.25M | 104.78M | 84.87M | 63.80M | 47.10M | 31.50M | 18.90M | 12.80M | 8.00M | 4.80M |
| Gross Profit Ratio | 56.67% | 55.78% | 56.57% | 57.53% | 58.09% | 58.95% | 58.21% | 58.15% | 58.00% | 60.24% | 63.65% | 62.11% | 59.97% | 59.63% | 60.01% | 60.15% | 59.10% | 53.68% | 62.09% | 64.60% | 63.87% | 63.27% | 65.29% | 67.53% | 73.41% | 72.01% | 70.83% | 64.02% | 54.62% | 54.47% | 57.55% | 62.34% |
| Research & Development | 307.53M | 287.64M | 253.58M | 225.28M | 201.95M | 180.65M | 155.15M | 144.47M | 118.65M | 114.87M | 118.23M | 120.12M | 109.73M | 92.01M | 75.20M | 63.06M | 60.52M | 50.11M | 37.22M | 30.01M | 26.17M | 20.53M | 14.91M | 11.15M | 8.50M | 6.50M | 5.00M | 3.80M | 2.80M | 0.00 | 0.00 | 0.00 |
| General & Administrative | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 600.37M | 553.97M | 488.06M | 478.63M | 450.41M | 430.80M | 401.62M | 372.25M | 331.86M | 289.88M | 278.09M | 237.33M | 200.17M | 135.70M | 104.71M | 85.31M | 64.48M | 49.91M | 36.99M | 27.40M | 21.10M | 16.80M | 11.10M | 0.00 | 0.00 | 0.00 |
| Selling & Marketing | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -5.46M | -6.00M | 0.00 | 0.00 | 0.00 | -1.00M | -3.00M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A | 917.14M | 874.00M | 739.37M | 670.39M | 676.69M | 645.01M | 600.37M | 553.97M | 482.59M | 472.63M | 450.41M | 430.80M | 401.62M | 371.25M | 328.86M | 289.88M | 278.09M | 237.33M | 200.17M | 135.70M | 104.71M | 85.31M | 64.48M | 49.91M | 36.99M | 27.40M | 21.10M | 16.80M | 11.10M | 9.40M | 6.40M | 3.90M |
| Other Expenses | 110.75M | -5.71M | 31.08M | 31.08M | 30.09M | 74.94M | -8.54M | 4.10M | 4.96M | 6.25M | 884.00K | -2.19M | 8.46M | 10.15M | 8.04M | 7.06M | 9.79M | 6.90M | 7.09M | 1.37M | 500.00K | 0.00 | 104.67M | 0.00 | 6.25M | 4.60M | 3.70M | 2.60M | 1.30M | 600.00K | 300.00K | 200.00K |
| Operating Expenses | 1.34B | 1.20B | 1.02B | 926.75M | 908.73M | 900.60M | 801.90M | 745.01M | 625.17M | 596.16M | 578.37M | 585.83M | 525.33M | 473.40M | 412.10M | 359.99M | 348.40M | 294.33M | 244.47M | 167.09M | 131.38M | 105.85M | 184.06M | 61.06M | 51.73M | 38.50M | 29.80M | 23.20M | 15.20M | 10.00M | 6.70M | 4.10M |
| Cost & Expenses | 3.37B | 3.07B | 2.58B | 2.28B | 2.15B | 1.97B | 1.78B | 1.61B | 1.40B | 1.26B | 1.14B | 1.16B | 1.07B | 975.22M | 848.98M | 726.92M | 690.05M | 626.17M | 474.57M | 317.73M | 253.98M | 206.33M | 254.89M | 111.44M | 82.48M | 63.30M | 49.20M | 40.90M | 30.90M | 20.70M | 12.60M | 7.00M |
| Interest Income | 0.00 | 47.38M | 22.31M | 362.00K | 1.02M | 2.30M | 16.38M | 17.09M | 16.86M | 26.21M | 31.24M | 38.87M | 33.87M | 27.80M | 16.70M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Expense | 45.71M | 47.38M | 22.31M | 23.99M | 40.38M | 36.16M | 28.36M | 28.24M | 11.21M | 5.78M | 6.13M | 6.39M | 4.79M | 1.76M | 10.06M | 10.06M | 10.06M | 1.32M | 1.32M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Depreciation & Amortization | 216.21M | 196.52M | 193.84M | 191.52M | 181.37M | 150.80M | 119.96M | 112.16M | 86.85M | 73.06M | 9.73M | 10.14M | 13.97M | 10.15M | 8.04M | 7.06M | 59.49M | 48.14M | 41.62M | 29.13M | 17.87M | 12.58M | 9.97M | 8.45M | 6.25M | 4.60M | 3.70M | 2.60M | 1.30M | 600.00K | 300.00K | 200.00K |
| EBITDA | 1.53B | 1.36B | 1.18B | 1.10B | 990.43M | 705.80M | 680.22M | 568.89M | 522.72M | 482.29M | 484.87M | 469.79M | 422.59M | 374.32M | 322.15M | 190.31M | 204.83M | 90.16M | 174.04M | 136.90M | 85.36M | 79.82M | -40.84M | 52.16M | 39.39M | 29.90M | 21.00M | 10.90M | 4.90M | 3.40M | 1.60M | 900.00K |
| EBITDA Ratio | 32.73% | 31.72% | 33.37% | 34.80% | 33.47% | 32.36% | 29.85% | 29.02% | 29.40% | 29.44% | 27.49% | 24.10% | 22.68% | 23.31% | 22.73% | 22.07% | 24.47% | 19.12% | 28.86% | 34.72% | 30.28% | 28.29% | -21.95% | 43.70% | 33.87% | 35.44% | 33.53% | 16.46% | 5.78% | 10.21% | 7.91% | 3.90% |
| Operating Income | 1.32B | 1.13B | 1.00B | 903.68M | 809.66M | 579.26M | 541.83M | 425.80M | 428.95M | 409.24M | 405.09M | 354.82M | 294.41M | 266.92M | 240.38M | 190.31M | 142.97M | 90.16M | 131.30M | 97.35M | 85.36M | 67.24M | -51.16M | 26.04M | 33.14M | 25.30M | 17.30M | 8.30M | 3.70M | 2.80M | 1.30M | 700.00K |
| Operating Income Ratio | 28.17% | 26.80% | 27.96% | 28.27% | 27.38% | 22.22% | 23.15% | 20.60% | 23.33% | 24.38% | 26.05% | 23.43% | 21.51% | 21.47% | 22.01% | 20.67% | 17.11% | 12.59% | 21.63% | 22.88% | 25.16% | 24.58% | -25.07% | 16.78% | 28.66% | 28.56% | 26.02% | 16.87% | 10.69% | 11.91% | 9.35% | 9.09% |
| Total Other Income/Expenses | -55.10M | -30.21M | -39.80M | -20.02M | -76.57M | -60.42M | -20.52M | -7.06M | 10.61M | 26.68M | 25.99M | 30.30M | 37.54M | 36.78M | 20.21M | 11.37M | 14.89M | 7.81M | 2.09M | -727.00K | -693.00K | -113.00K | 105.75M | 1.27M | 1.03M | -700.00K | -1.20M | 2.80M | 2.90M | 900.00K | 500.00K | 500.00K |
| Income Before Tax | 1.26B | 1.10B | 960.48M | 883.66M | 733.09M | 518.85M | 521.31M | 418.74M | 439.57M | 435.92M | 431.08M | 385.12M | 331.95M | 303.71M | 260.59M | 201.68M | 157.86M | 97.97M | 133.39M | 96.63M | 84.67M | 67.13M | 54.59M | 27.31M | 34.17M | 24.60M | 16.10M | 11.10M | 6.60M | 3.70M | 1.80M | 1.20M |
| Income Before Tax Ratio | 27.00% | 26.09% | 26.84% | 27.64% | 24.79% | 19.91% | 22.28% | 20.26% | 23.91% | 25.96% | 27.72% | 25.43% | 24.26% | 24.43% | 23.86% | 21.90% | 18.90% | 13.68% | 21.98% | 22.71% | 24.95% | 24.54% | 26.75% | 17.60% | 29.55% | 27.77% | 24.21% | 22.56% | 19.08% | 15.74% | 12.95% | 15.58% |
| Income Tax Expense | 243.85M | 204.11M | 181.05M | 409.16M | 111.41M | 114.26M | 205.72M | 76.46M | 87.16M | 83.03M | 85.81M | 77.99M | 77.10M | 76.72M | 70.50M | 55.24M | 47.55M | 31.67M | 45.18M | 31.84M | 27.38M | 21.40M | 17.09M | 15.68M | 11.94M | 8.50M | 5.50M | 3.60M | 2.10M | 900.00K | 600.00K | 400.00K |
| Net Income | 1.02B | 897.56M | 779.44M | 474.51M | 621.67M | 404.59M | 315.59M | 342.28M | 352.41M | 352.89M | 345.27M | 307.13M | 254.85M | 226.99M | 190.09M | 146.45M | 110.30M | 66.30M | 88.21M | 64.79M | 57.28M | 45.73M | 37.51M | 11.63M | 22.23M | 16.10M | 10.60M | 7.50M | 4.50M | 2.80M | 1.20M | 800.00K |
| Net Income Ratio | 21.79% | 21.25% | 21.78% | 14.84% | 21.02% | 15.52% | 13.49% | 16.56% | 19.17% | 21.02% | 22.20% | 20.28% | 18.62% | 18.26% | 17.40% | 15.91% | 13.20% | 9.26% | 14.53% | 15.23% | 16.88% | 16.72% | 18.38% | 7.50% | 19.22% | 18.17% | 15.94% | 15.24% | 13.01% | 11.91% | 8.63% | 10.39% |
| EPS | 6.94 | 6.12 | 5.34 | 3.27 | 4.31 | 2.83 | 2.21 | 2.42 | 2.51 | 2.51 | 2.44 | 2.15 | 1.75 | 1.49 | 1.26 | 0.97 | 0.72 | 0.43 | 0.61 | 0.47 | 0.43 | 0.35 | 0.29 | 0.09 | 0.19 | 0.14 | 0.09 | 0.06 | 0.04 | 0.04 | 0.02 | 0.02 |
| EPS Diluted | 6.92 | 6.09 | 5.30 | 3.24 | 4.27 | 2.80 | 2.19 | 2.40 | 2.49 | 2.47 | 2.39 | 2.10 | 1.71 | 1.44 | 1.23 | 0.95 | 0.70 | 0.43 | 0.58 | 0.46 | 0.41 | 0.33 | 0.28 | 0.09 | 0.17 | 0.13 | 0.09 | 0.06 | 0.04 | 0.04 | 0.02 | 0.02 |
| Weighted Avg Shares Out | 147.02M | 146.77M | 146.07M | 145.31M | 144.34M | 143.11M | 142.76M | 141.36M | 140.24M | 140.47M | 141.47M | 142.95M | 145.90M | 152.47M | 150.91M | 151.26M | 154.76M | 153.42M | 144.61M | 137.29M | 134.78M | 132.22M | 128.70M | 124.52M | 120.61M | 117.66M | 116.16M | 117.07M | 112.50M | 70.00M | 53.33M | 48.00M |
| Weighted Avg Shares Out (Dil) | 147.55M | 147.46M | 147.04M | 146.45M | 145.65M | 144.48M | 143.99M | 142.45M | 141.67M | 142.69M | 144.36M | 146.41M | 149.32M | 157.20M | 155.10M | 154.23M | 157.42M | 156.51M | 154.32M | 149.88M | 140.50M | 137.76M | 136.32M | 133.94M | 129.21M | 124.27M | 120.28M | 117.07M | 112.50M | 70.00M | 53.33M | 48.00M |
RMD Stock Likely to Gain From Enhanced Digital Sleep Health Solutions
ResMed Unveils 2030 Strategy to Drive Growth, Profitability, and Shareholder Returns
UPDATE -- ResMed Unveils New Collection of Digital and Personalized Solutions designed to Improve Sleep Health
UPDATE -- ResMed Enhances CPAP Therapy with its First Fabric Mask, Designed to Make it Easier for People to Embrace Their Treatment and Improve Overall Sleep Health
ResMed Enhances CPAP Therapy with its First Fabric Mask, Designed to Make it Easier for People to Embrace Their Treatment and Improve Overall Sleep Health
ResMed Unveils New Collection of Digital and Personalized Solutions designed to Improve Sleep Health
ResMed: Growing Returns With Continuous Acquisitions Led To A Margin Of Safety
S&P 500 Gains and Losses Today: ResMed Drops as Weight-Loss Drugs Threaten Demand
Why ResMed Stock Tumbled by 5% Today
Why ResMed's Rally Is Just Getting Started
Source: https://incomestatements.info
Category: Stock Reports